Example searches

MGLN Magellan Health, Inc.

Magellan Health, Inc. engages in the business of healthcare management. It operates through the following segments: Healthcare, Pharmacy Management and Corporate. The Healthcare segment comprises of the Commercial and Government reporting units. The Pharmacy Management segment offers products and solutions that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit. The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Phoenix, AZ.

Company profile

Ticker
MGLN
Exchange
NASDAQ
Website
www.magellanhealth.com
CEO
Kenneth J. Fasola
Employees
Incorporated in
Delaware
Location
Arizona
Fiscal year end
Dec 31
Sector
Health Services > Managed Health Care
Industry (SEC)
Services - Hospitals
Encompass Health • Select Medical • JRSIS HEALTH CARE • Spine Injury Solutions • MEDNAX ...
Former names
Charter Medical Corp, Magellan Health Services Inc
SEC CIK
0000019411
Corporate docs
IRS number
581076937

MGLN stock data

(
)
FINRA relative short interest over last month (20 trading days) ?

Calendar

28 Feb 20
4 Apr 20
31 Dec 20

News

Company financial data Financial data

Chart MGLN financial data
Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 1.8B 1.83B 1.79B 1.74B
Net income 20.58M 21.27M 13.61M 431K
Diluted EPS 0.83 0.86 0.56 0.02
Net profit margin 1.14% 1.16% 0.76% 0.02%
Net change in cash 307.75M 13.2M -9.3M 4.8M
Cash on hand 325.25M 17.5M 4.3M 13.6M
Cost of revenue 465.61M 482.28M 461.19M 489.79M
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 7.16B 7.31B 5.84B 4.84B
Net income 55.9M 24.18M 110.21M 77.88M
Diluted EPS 2.28 0.97 4.51 3.22
Net profit margin 0.78% 0.33% 1.89% 1.61%
Net change in cash 316.45M -105.9M -12.3M -33.2M
Cash on hand 325.25M 8.8M 114.7M 127M
Cost of revenue 1.9B 2.28B 2.21B 1.82B

Financial data from company earnings reports

Recent insider trades

MGLN insider ownership history Insider history
Date Owner Security Transaction Code $Price #Shares $Value #Remaining
5 Mar 20 Jeffrey N West Ordinary Common Stock, $0.01 par value Payment of exercise Dispose F 60.03 429 25.75K 23,015
5 Mar 20 Jeffrey N West Ordinary Common Stock, $0.01 par value Payment of exercise Dispose F 60.03 244 14.65K 21,996
5 Mar 20 Jeffrey N West Ordinary Common Stock, $0.01 par value Option exercise Aquire M 0 839 0 22,240
5 Mar 20 Jeffrey N West RSU Common Stock Option exercise Dispose M 0 1,448 0 2,894
5 Mar 20 Jeffrey N West Restricted Stock Common Stock Option exercise Dispose M 0 839 0 839
5 Mar 20 Jeffrey N West Ordinary Common Stock, $0.01 par value Option exercise Aquire M 0 1,448 0 23,444
4 Mar 20 James E Murray RSU Common Stock Grant Aquire A 0 21,850 0 21,850
4 Mar 20 Clapper Caskie Lewis RSU Common Stock Grant Aquire A 0 6,085 0 6,085
4 Mar 20 Jonathan N Rubin RSU Common Stock Grant Aquire A 0 15,763 0 15,763
4 Mar 20 Jonathan N Rubin RSU Common Stock Grant Aquire A 0 13,134 0 13,134
Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2019

MGLN institutional ownership history Ownership history
13F holders
 Current Prev Q Change
Total holders 207 208 -0.5%
Opened positions 29 39 -25.6%
Closed positions 30 34 -11.8%
Increased positions 66 69 -4.3%
Reduced positions 74 67 +10.4%
13F shares
 Current Prev Q Change
Total value 4.67B 3.3B +41.3%
Total shares 24.51M 23.48M +4.4%
Total puts 52.2K 124.1K -57.9%
Total calls 114.8K 35.7K +221.6%
Total put/call ratio 0.5 3.5 -86.9%
Largest owners
 Shares Value Change
BLK BlackRock 3.47M $271.57M +3.9%
Vanguard 2.37M $185.51M +0.2%
Starboard Value 2.37M $185.38M 0.0%
Dimensional Fund Advisors 2.05M $160.16M +1.0%
Victory Capital Management 1.21M $94.61M +65.4%
STT State Street 889.12K $69.57M +4.6%
JPM JPMorgan Chase & Co. 825.11K $64.57M +11.5%
NTRS Northern Trust 763.79K $59.77M -0.9%
Renaissance Technologies 673.82K $52.73M +6.3%
Brown Advisory 476.38K $37.28M -0.1%
Largest transactions
 Shares Bought/sold Change
Victory Capital Management 1.21M +478.21K +65.4%
Norges Bank 349.99K +349.99K NEW
Snow Capital Management 184.72K -290.18K -61.1%
GS The Goldman Sachs Group, Inc. 316.84K +237.46K +299.1%
Omni Partners 0 -230.5K EXIT
Voya Investment Management 375.92K +228.33K +154.7%
Millennium Management 366.81K +136K +58.9%
Point72 Asset Management 130.68K +130.68K NEW
BLK BlackRock 3.47M +130.15K +3.9%
Dean Investment Associates 0 -92.65K EXIT
Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

?
Competition
Cigna
Management Discussion
  • Net revenue, cost of care, cost of goods sold, and direct service costs and other operating expense variances are addressed within the segment results that follow.
  • Depreciation and amortization expense decreased by 0.9 percent or $1.1 million from 2018 to 2019, primarily due to asset maturation after 2018.
  • Interest expense increased by $0.8 million from 2018 to 2019 mainly due to higher interest rates.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: accuracy, acute, alter, assigned, automatically, Budget, budgeting, CCC, Description, diament, distribution, embedded, ESQ, estate, fasola, feld, grown, guy, Inline, Interactive, iXBRL, kenneth, land, leslie, LP, malfeasance, michael, Murray, NaN, norwalk, OMB, opportunity, package, peter, Phoenix, quantitative, quantitatively, readily, real, reiterated, rigor, ROU, routine, Rutledge, sansone, SCO, shulman, slightly, Starboard, steven, Supreme, terrorism, twelve
Removed: administering, agile, Agwunobi, Alliance, ceased, Chairman, competing, complementary, copy, deductible, define, delayed, denominated, Director, discussing, disorder, essential, experiencing, fastest, forward, grandfathered, Granite, hour, identifying, IFR, increasingly, John, ordinary, placement, provisional, publish, publisher, refinancing, Rent, Sam, Scottsdale, sooner, Srivastava, sublease, sublimit, suite, supplier, switching, unlawful, vast, volume, warranted
From filing 10-K 2019 FY

Financial reports

View all
10-K
2019 FY
Annual report
28 Feb 20
10-Q
2019 Q3
Quarterly report
1 Nov 19
10-Q
2019 Q2
Quarterly report
30 Jul 19
10-Q
2019 Q1
Quarterly report
2 May 19
10-K
2018 FY
Annual report
28 Feb 19
10-Q
2018 Q3
Quarterly report
7 Nov 18
10-Q
2018 Q2
Quarterly report
27 Jul 18
10-Q
2018 Q1
Quarterly report
26 Apr 18
10-K
2017 FY
Annual report
1 Mar 18
10-Q
2017 Q3
Quarterly report
1 Nov 17

Current reports

View all
8-K
Departure of Directors or Certain Officers
10 Mar 20
8-K
Magellan Health Reports 2019 Financial Results and Three Months Ended
28 Feb 20
8-K
Other Events
20 Feb 20
8-K
Magellan Health Board of Directors Appoints David Haddock as General Counsel and Secretary of Magellan Health
3 Feb 20
8-K
Other Events
23 Dec 19
8-K
Magellan Health Board of Directors Appoints James Murray as President and Chief Operating Officer of Magellan Health
5 Dec 19
8-K
Departure of Directors or Certain Officers
12 Nov 19
8-K
Other Events
8 Nov 19
8-K
Magellan Health Reports Third Quarter 2019 Financial Results
1 Nov 19
8-K
Magellan Health Board of Directors Appoints Kenneth J. Fasola as Chief Executive Officer
31 Oct 19

Registration and prospectus

View all
S-8
Registration of securities for employees
12 Jun 18
424B2
Prospectus for primary offering
18 Sep 17
424B2
Prospectus for primary offering
15 Sep 17
FWP
Free writing prospectus
15 Sep 17
S-3ASR
Automatic shelf registration
31 Aug 17
S-8
Registration of securities for employees
29 Jul 16
S-8
Registration of securities for employees
3 Jun 14
S-8
Registration of securities for employees
18 May 11
S-8
Registration of securities for employees
18 May 11
S-8
Registration of securities for employees
21 May 08

Proxies

View all
DEF 14A
Definitive proxy
29 Apr 19
DEFA14A
Additional proxy soliciting materials
22 Feb 19
DFAN14A
Additional proxy materials by non-management
22 Feb 19
DEF 14A
Definitive proxy
9 Apr 18
DEF 14A
Definitive proxy
12 Apr 17
PRE 14A
Preliminary proxy
21 Mar 17
DEF 14A
Definitive proxy
8 Apr 16
DEFA14A
Additional proxy soliciting materials
29 Apr 15
DEFA14A
Additional proxy soliciting materials
17 Apr 15
DEF 14A
Definitive proxy
10 Apr 15

Other

View all
UPLOAD
Letter from SEC
30 May 17
CORRESP
Correspondence with SEC
19 May 17
UPLOAD
Letter from SEC
10 May 17
UPLOAD
Letter from SEC
1 Sep 16
CORRESP
Correspondence with SEC
29 Aug 16
CT ORDER
Confidential treatment order
23 Aug 16
UPLOAD
Letter from SEC
2 Aug 16
UPLOAD
Letter from SEC
10 Sep 15
CORRESP
Correspondence with SEC
11 Aug 15
UPLOAD
Letter from SEC
31 Jul 15

Ownership

View all
4
MAGELLAN HEALTH / JEFFREY N WEST ownership change
9 Mar 20
4
MAGELLAN HEALTH / JAMES E MURRAY ownership change
6 Mar 20
4
MAGELLAN HEALTH / Jonathan N Rubin ownership change
6 Mar 20
4
MAGELLAN HEALTH / Mostafa Kamal ownership change
6 Mar 20
4
MAGELLAN HEALTH / Clapper Caskie Lewis ownership change
6 Mar 20
4
MAGELLAN HEALTH / JEFFREY N WEST ownership change
6 Mar 20
4
MAGELLAN HEALTH / KENNETH J FASOLA ownership change
6 Mar 20
4
MAGELLAN HEALTH / Clapper Caskie Lewis ownership change
5 Mar 20
4
MAGELLAN HEALTH / JEFFREY N WEST ownership change
5 Mar 20
4
MAGELLAN HEALTH / Mostafa Kamal ownership change
5 Mar 20